Lotte E. Elshof
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
Journal: British journal of cancer
Published: December 04, 2020
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.
Journal: The American journal of surgical pathology
Published: June 18, 2019
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ-A Nested Case-Control Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 30, 2018
Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Journal: Breast cancer research and treatment
Published: November 24, 2016
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Journal: Breast cancer research : BCR
Published: October 07, 2016
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
Journal: Breast cancer research and treatment
Published: August 31, 2016
Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Journal: Breast (Edinburgh, Scotland)
Published: May 26, 2016
Ductal carcinoma in situ: the balance between over- and undertreatment
Journal: Nederlands tijdschrift voor geneeskunde
Published: April 14, 2016
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 05, 2014
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
Journal: European journal of radiology
Published: July 11, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026